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Abstract
Background: Hemodialysis (HD) and peritoneal dialysis (PD) are important renal replacement
treatment in end stage renal disease (ESRD), but the comparison of quality of life (QOL) and causes
of hospitalisation between the two modalities in China is lacking. In the present study, we
compared the two modalities in a multi-center study.
Subjects and methods: Six hundred and fifty four HD and 408 PD patients were investigated
from 10 hospitals in China from Sept, 2004 to Jan, 2005. Among the HD patients, there were 360
males and 294 females with a mean age of 57.22 ± 12.49 years (18–88 y). Among PD patients, there
were 165 males and 243 females, with a mean age of 61.59 ± 12.65 years (22–89 y). Health related
36 items short form questionnaires (SF-36) were used to assess the quality of life. Hospitalisation
data were collected and analyzed.
Results: SF-36 domains of Body Pain (BP), General Health (GH), Role-Emotional (RE), Social
Functioning (SF), Vitality (VT) and Mental Health (MH) were all significantly higher in the PD
patients as compared to the HD patients although there was no significant difference in Physical
Functioning (PF) and Role-Physical (RP) between the two groups. The two most common causes
of hospitalisation in HD patients were cardiovascular disease (39.8%) and pulmonary infection
(21.3%), while they were infectious peritonitis (47.6%) and cardiovascular disease (31.9%) in PD
patients. The ever hospitalised patients had lower SF-36 scores in the domains of PF, BP, GH, RE,
SF, VT and MH as compared to those of non-hospitalised patients.
Conclusion: Our study indicated that with the current practice in China, PD patients may enjoy
better quality of life than their HD counterparts. Our results also showed that the most common
cause of hospitalisation was cardiovascular disease in HD patients and peritonitis in PD patients.
Background
Both hemodialysis (HD) and peritoneal dialysis (PD) are
established renal replacement therapies to treat patients
with end-stage renal disease (ESRD) worldwide. Accord-
ing to the data of Registry of Dialysis and Transplantation
in 2005 in China, there were about 59,000 dialysis
patients in this country and 90% of them were on HD.
Although HD and PD are thought to provide similar ben-
efits to ESRD patients, the actual large scale comparisons
of quality of life (QOL) and causes of hospitalisation
Published: 2 August 2007
Health and Quality of Life Outcomes 2007, 5:49 doi:10.1186/1477-7525-5-49
Received: 25 April 2007
Accepted: 2 August 2007
This article is available from: http://www.hqlo.com/content/5/1/49
© 2007 Zhang et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Health and Quality of Life Outcomes 2007, 5:49 http://www.hqlo.com/content/5/1/49
Page 2 of 6
(page number not for citation purposes)
between the two modalities is currently lacking in China.
In literatures, health related 36 items short form question-
naires (SF-36) were used increasingly to assess the QOL in
the studies of ESRD patients [1-4]. So we employed SF-36
as a tool and investigated the QOL and causes of hospital-
isation in HD and PD patients in China based on multi-
center data in the present study.
Subjects and Methods
Data collection
Demographic and clinical data of 661 HD patients and
412 PD patients were derived from 10 big hospitals
located in different cities in China from Sept, 2004 to Jan,
2005. Demographic information and clinical history were
collected through review of medical records and self-
reported SF-36 questionnaires. We categorized socio-
demographic variables as follows: age, currently marriage
status (yes/no), employment status (yes/no). Comorbid-
ity was assessed by using Charlson Cormobidity Index,
with higher score reflecting increased severity of disease[5-
8].
SF-36 questionnaire
The SF-36 questionnaires were the main tool to assess
QOL in dialysis patients[1-4]. The SF-36 was finally eval-
uated in eight domains: Physical Functioning (PF,10
items), Role-Physical (RP,4 items), Body Pain (BP,2
items), General Health (GH,5 items), Role-Emotional
(RE,3 items), Social Functioning (SF,2 items), Vitality
(VT,4 items) and Mental Health (MH,5 items). The score
for each domain range from 0 to 100 with higher scores
indicates better quality of life [1-4].
Hospitalisation
Retrospective hospitalisation data were collected for year
2004. Among all the patients, 757 patients had complete
data and were enrolled for the hospitalisation analysis,
but only 309 patients of them were defined hospitalisa-
tion, the other were defined non-hospitalisation for
access-related hospitalisation (HD patients artery-venous
fistula operation, PD catheter implantation) and trans-
planted-related hospitalisation were excluded. Hospital
admissions for a variety of disorders were analyzed [12].
Statistical analysis
Demographic and clinical data were described as mean ±
SD for continuous variables. The differences in demo-
graphic data and SF-36 scores between PD and HD groups
were analyzed by independent t tests for normally distrib-
uted variables or nonparametric tests for non-normally
distributed variables. The effects of age, gender, diabetic
status and Charlson index were adjusted by covariate
analysis. To perform covariate analysis, the logarithmi-
cally transformed SF-36 scores were treated as dependent
variables, while the modality of dialysis was treated as a
fixed factor and the age, gender, diabetic status and Charl-
Table 1: Demographic data of the dialysis patients
HD(N = 654) Percentage PD(N = 408) Percentage
Characteristic
Age
<40 51 7.7% 26 6.3%
40–49 135 20.6% 34 8.3%
50–59 167 25.5% 111 27.2%
60–69 195 29.8% 121 29.7%
70–79 94 14.4% 96 23.5%
80+ 12 1.8% 20 4.9%
Age(mean) 57.22 ± 12.49 61.59 ± 12.65
Gender
% female 294 45.0% 243 59.6%
Employment
Employed 20 3.0% 30 7.4%
Marital status
%current married 609 93.11% 390 95.58%
Charlson comorbidity Index 4.78 ± 1.06 4.30 ± 0.58
Cause of ESRD
Glomerulonephritis 301 46.0% 195 47.8%
Hypertensive nephropathy 110 16.8% 63 15.4%
Diabetic nephropathy 99 15.1% 42 10.2%
Drug-induced renal lesion 88 13.5% 39 9.6%
Unknown cause 45 6.9% 53 13.0%
Others 9 3.2% 16 4.0%
Abbreviations: ESRD, end-stage renal disease.Health and Quality of Life Outcomes 2007, 5:49 http://www.hqlo.com/content/5/1/49
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son index as covariates. P < 0.05 was considered as statis-
tically significant. Statistical analyses were performed
using SPSS 11.0 version.
Results
1. Characteristics of the studied dialysis patients
Of the 1073 patients enrolled in the study, 1062 com-
pleted the SF-36 questionnaire (98.9% of responding
rate). Table 1 showed relevant socio-demographic and
clinical characteristics of the 1062 respondents. The
results showed that the PD patients were elder than the
hemodialysis patients (P = 0.000), and there were more
female patients in PD patients than that in hemodialysis
patients (59.6% vs. 45.0%, P = 0.000). Less than 10% of
dialysis patients were employed (HD 3.0% vs. PD 7.4%, P
= 0.219). The PD patients had lower Charlson index than
HD patients (4.30 ± 0.58 vs. 4.78 ± 1.06, P = 0.000). The
causes of ESRD were glomerlulonephritis (HD 46.0% and
PD 47.8%), hypertensive nephropathy (HD 16.8% and
PD 15.4%), diabetic nephropathy (15.1% in HD vs.
10.2% in PD, P = 0.024), drug-induced renal damage (HD
13.5% and PD 9.6%).
2. Comparisons of quality of life
The average scores for SF-36 domains of BP, GH, RE, SF,
VT and MH were higher in PD patients than those in HD
patients except PF and RP. This difference was still signifi-
cant even after adjustment of age, gender, diabetic status
and Charlson index by covariate analysis (Table 2). How-
ever, there were no significant differences between the dia-
betic patients and non-diabetic patients in terms of
physical health and health dimensions, neither between
the female and male patients (Table 3 and Table 4).
3.   Analysis of the causes of hospitalisation in dialysis patients 
HD patients had higher hospitalisation as compared to
PD patients (47.8%vs 29.7%, P=0.000). In HD patients,
the two most common causes of hospitalisation were car-
diovascular diseases and infection (especially pulmonary
infection), while they were infection (especially infectious
peritonitis) and cardiovascular diseases in PD patients
(Table 5).   
4. The comparison of SF-36 domains between hospitalised 
and non-hospitalised dialysis patients
Among the two major domains of the SF-36, the physical
health dimension scores were also statistically different
between the hospitalised patients and non-hospitalised
patients, and the ever hospitalised patients had significant
lower SF-36 domain scores (containing PF, BP, GH, RE,
SF, VT, MH, see in Table 6).
Table 3: Comparison of quality of life between gender groups.
SF36 domain Male (n = 525) Female(n = 537) P
PF 45.17 ± 30.17 46.90 ± 30.29 0.398
RP 23.76 ± 43.72 25.56 ± 44.46 0.182
BP 43.58 ± 23.93 45.83 ± 27.64 0.156
GH 30.40 ± 19.98 32.17 ± 21.01 0.215
RE 47.94 ± 48.32 48.48 ± 48.80 0.877
SF 51.19 ± 22.57 53.56 ± 26.28 0.069
VT 39.71 ± 23.56 40.41 ± 23.74 0.098
MH 62.68 ± 23.71 63.01 ± 23.08 0.433
Abbreviations: PF, Physical Functioning; RP, Role-Physical; BP, Body Pain; GH, General Health; RE, Role-Emotional; SF, Social Functioning; VT, 
Vitality; MH, Mental Health.
Table 2: Comparison of SF-36 scores between PD and HD patients.
SF-36 Domain HD (n = 654) PD (n = 408) Unadjusted P Adjusted P
PF 45.07 ± 30.86 49.88 ± 30.63 0.065 0.098
RP 22.36 ± 45.61 26.41 ± 48.05 0.109 0.176
BP 43.02 ± 22.92 52.16 ± 26.21 0.000 0.000
GH 27.65 ± 18.82 36.75 ± 21.72 0.000 0.000
RE 42.36 ± 47.94 57.65 ± 48.06 0.000 0.000
SF 48.89 ± 25.20 56.71 ± 25.02 0.000 0.001
VT 36.67 ± 22.58 45.40 ± 24.30 0.000 0.006
MH 58.77 ± 23.56 68.08 ± 21.83 0.000 0.009
Abbreviations: PF, Physical Functioning; RP, Role-Physical; BP, Body Pain; GH, General Health; RE, Role-Emotional; SF, Social Functioning; VT, 
Vitality; MH, Mental Health.Health and Quality of Life Outcomes 2007, 5:49 http://www.hqlo.com/content/5/1/49
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Discussion
Previous study reported that there was no simple answer
to the question of which dialysis modality could be
expected to provide better quality of life [9,10]. Several
studies suggested advantages for PD in some domains
[11,12], and HD in others [3] or little difference between
the two modalities[13,15].
The current study performed in China showed that PD
patients reported better quality of life in mental health
dimensions, GH (Combined mental health dimensions
and physical health dimensions) and BP of physical
health dimensions than HD patients except PF and RP if
non-matched demographic data were not adjusted. This
difference remained significant after adjustment of the
patients' characteristics. It was interesting that we failed to
demonstrate that diabetic status affected QOL, which was
contrasted to some studies [2], but consisted with our pre-
vious investigations [14]. The exact cause for better QOL
in Chinese PD patients is not clearly at present, but we
believe that the following reasons should be considered.
Firstly, the lower body mass index in Chinese patients
may be translated as an adequate dialysis could be
achieved with a relatively lower dialysis dose. Indeed,
there are reports that the survival in Hong Kong Chinese
PD patients is better than that in Caucasian patients in
Western world, although the former have relatively lower
Kt/V [16]. Secondly, it is reported that the micro-inflam-
mation state, a predictor of cardiovascular event in dialy-
sis patients [17], is lower in Asian patients than that in
Western patients [18], which may be due to the difference
in race and/or dietary habits.
Our current study also showed that the RP score in Chi-
nese dialysis patients was low, consisting with the low
employment rate (HD 3.2%, PD 7%) observed in this
study. This might be due to the following reasons: Firstly,
many Chinese patients do not accept the concept of
timely dialysis until they suffer more and severer comor-
bidity; Secondly, the Chinese dialysis patients usually
depend on the care of their family members (their chil-
dren, spouse, sisters and brothers, parents, etc); Thirdly,
Chinese dialysis patients are often not re-employed
because of their end stage renal disease.
The current study showed that the cause of hospitalisation
differed between PD and HD. In our HD patients, cardio-
vascular disease was most common cause and infection
ranked the second. Moreover, majority of cause of hospi-
talisation were congestive heart failure in HD patients.
Our results were consisted with some previous reports.
Rayner [19] reported that cardiac disease was a common
cause of death in chronic hemodialysis patients. A sub-
analysis of the data on cardiac diseases in the Hemodialy-
sis (HEMO) Study by Cheung[20] found that among the
total of 1685 cardiac hospitalisations, angina and acute
Table 5: Cause of hospitalisation for dialysis patients (number of patients)
Cause of hospitalisation HD PD
Infection-related 47*# 41*#
Cardiovascular disease 89*# 30*#
Hemorrhage 21
Vascular access 34
PD technique problem 7
Others 32 8
Total 223 86#
* P < 0.01 Compared with within HD and PD patients by Chi-square test
# P < 0.01 Compared between HD and PD patients by Chi-square test
Table 4: Comparison of quality of life between diabetic and non-diabetic patients
SF-36 domain Non-diabetic(n = 921) Diabetic(n = 141) P
PF 50.45 ± 28.09 44.19 ± 30.96 0.134
RP 28.37 ± 46.60 23.24 ± 46.57 0.117
BP 46.16 ± 24.72 49.10 ± 24.31 0.313
GH 31.17 ± 19.54 31.15 ± 20.60 0.846
RE 49.72 ± 47.16 47.93 ± 48.76 0.792
SF 52.74 ± 26.05 51.76 ± 25.32 0.598
VT 42.13 ± 24.83 39.71 ± 28.43 0.269
MH 62.16 ± 21.65 62.38 ± 28.63 0.846
Abbreviations: PF, Physical Functioning; RP, Role-Physical; BP, Body Pain; GH, General Health; RE, Role-Emotional; SF, Social Functioning; VT, 
Vitality; MH, Mental Health.Health and Quality of Life Outcomes 2007, 5:49 http://www.hqlo.com/content/5/1/49
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myocardial infarction accounted for 42.7% of all the hos-
pitalisations. Allon M[21] reported infectious complica-
tion was common in hemodialysis patients and the
frequency of a severe outcome varied greatly by infectious
disease category, being highest for cardiac infections
(95.6%) and infection of unknown source (68.4%), and
lowest for urinary tract infections (35.5%) and access-
related infections (43.8%).
For PD patients, although majority of Chinese PD patients
have been using twin-bag system of Baxter Ltd since late
1990's, infectious disease especially peritonitis remained
to be the most common cause of hospitalisation in our
patients indicating further efforts are need to decreased
the incidence of peritonitis in this patient population.
Kalantar[22] reported that prospective hospitalisations of
hemodialysis patients correlated significantly with the SF-
36 total score and its two main dimensions. Our retro-
spective hospitalised patients had worse quality of life
than non-hospitalised patients, decreasing cormorbidities
should thus be an effective way to improve the quality of
life in dialysis patients.
In conclusion, although the present study is not a rand-
omized controlled study and the selection of dialysis
modality may have been biased in many aspects, our
study indicated that with the current practice in China, PD
patients may enjoyed better quality of life than their HD
counterparts. Our results also showed that the most com-
mon cause of hospitalisation was cardiovascular disease
in HD patients and peritonitis in PD patients.
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